Standard Biotools (LAB) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,738.00 |
| Dec 31, 2025 | 3,129.00 |
| Sep 30, 2025 | -14,700.00 |
| Jun 30, 2025 | -3,126.00 |
| Mar 31, 2025 | 50,232.00 |
| Dec 31, 2024 | -7,057.00 |
| Sep 30, 2024 | -5,061.00 |
| Jun 30, 2024 | -6,435.00 |
| Mar 31, 2024 | 1,396.00 |
| Dec 31, 2023 | 11,917.00 |
| Sep 30, 2023 | -3,204.00 |
| Jun 30, 2023 | -14.00 |
| Mar 31, 2023 | -1,473.00 |
| Dec 31, 2022 | 3,029.00 |
| Sep 30, 2022 | -5,036.00 |
| Jun 30, 2022 | -26,753.00 |
| Mar 31, 2022 | -22,044.00 |
| Sep 30, 2021 | 4,065.00 |
| Jun 30, 2021 | 1,077.00 |
| Mar 31, 2021 | 1,126.00 |
| Dec 31, 2020 | 151.00 |
| Sep 30, 2020 | 1,731.00 |
| Jun 30, 2020 | 329.00 |
| Mar 31, 2020 | -45,588.00 |
| Dec 31, 2019 | -642.00 |
| Sep 30, 2019 | -210.00 |
| Jun 30, 2019 | -284.00 |
| Mar 31, 2019 | -2,465.00 |
| Dec 31, 2018 | -2,357.00 |
| Sep 30, 2018 | -2,749.00 |
| Jun 30, 2018 | -3,831.00 |
| Mar 31, 2018 | -2,804.00 |
| Dec 31, 2017 | -1,453.00 |
| Sep 30, 2017 | -3,194.00 |
| Jun 30, 2017 | -3,555.00 |
| Mar 31, 2017 | -617.00 |
| Dec 31, 2016 | -4,397.00 |
| Sep 30, 2016 | -4,685.00 |
| Jun 30, 2016 | 185.00 |
| Mar 31, 2016 | 12,965.00 |
| Dec 31, 2015 | -979.00 |
| Sep 30, 2015 | 78,014.00 |
| Jun 30, 2015 | 683.00 |